[ad_1]
“I intend to actively participate in the debate on the European Certificate of Vaccines. In this regard, in Lithuania we agree that we support the idea of a vaccination certificate, and we are ready to discuss the extension of the certificate concept to include not only the vaccines themselves, the fact of vaccines, but also the development of immunity, ”said the European Council, said G.Nausėda.
The head of state emphasizes that “it would be really optimal” if such a document were recognized uniformly throughout the EU.
A vaccination passport or immunity document for those vaccinated against coronavirus and those suffering from the disease in Europe is being considered as a document that could grant certain privileges, such as for travelers, those wishing to attend events, etc.
Representatives of the Council of Experts convened by the Presidency emphasize that said document must cover both those vaccinated and all others with immunity against COVID-19.
Prime Minister Ingrida Šimonytė claims that during discussions at the EU level, Lithuania will not rush to introduce this innovation on its own until a sufficient part of the population has been vaccinated.
G.Nausėda: tools and opportunities need to be found to increase vaccine production capacity in the EU
The Lithuanian president says that Lithuania, along with Denmark, Belgium, Spain and Poland, has approached Charles Michel to find tools and opportunities for vaccine production capacity in the European Union.
“There is a lot of pressure in the European Union from member states to increase vaccine production and fight to multiply vaccine production by several in the second quarter of this year,” the head of state said after a meeting. remote from the European Council.
He stated that companies operating in Lithuania could also contribute to the production of vaccines.
We can service and find even more markets for our top manufacturers.
“We can offer services and find even more markets for our leading manufacturers that can contribute to the very noble work and implement plans to scale up vaccines, and not only in the next few years, but also in the near future,” said the president.
G. Nausėda also said that he had informed the President of the European Commission, Ursula von der Leyen, about the “importance in the production chain” of Thermo Fisher Scientific, a company that operates in Lithuania and produces reagents for vaccines.
According to the Lithuanian leader, when new manufacturers enter the market, the country should prepare for higher volumes of vaccines in the second quarter of the year.
“If such a breakthrough occurs, the aspiration of both the European Union and Lithuania to implement vaccination by the summer is possible and can be successfully completed,” said G. Nausėda.
The European Medicines Agency (EMA) was informed last week that it had received an application from Johnson & Johnson for approval of its coronavirus vaccine.
„Reuters“ / „Scanpix“ nuotr./ used Johnson & Johnson “vakcina
The AstraZeneca, Moderna and BioNTech and Pfizer vaccines are currently used in the European Union.
Previously, G. Nausėda has expressed his wish that around 70% be vaccinated by mid-summer. Lithuanian adult population. According to the calendar published by the Ministry of Health, the mass vaccination of the Lithuanian population is scheduled to start in May.
[ad_2]
